MidMichigan Medical Center-Midland is a 324-bed, non-profit hospital in Midland, Michigan. It is a member of MidMichigan Health, an integrated health delivery system affiliated with Michigan Medicine, the health care division of the University of Michigan.

There are 324 beds in MyMichigan Medical Center Midland.

During the past decade, MyMichigan Medical Center Midland conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MyMichigan Medical Center Midland" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MyMichigan Medical Center Midland" are "Recurrent Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "MyMichigan Medical Center Midland" in a lesser frequency.

Most popular intervention types in "MyMichigan Medical Center Midland" are "Other" (19 trials), "Drug" (17 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (7 trials), "Paclitaxel" (6 trials), "Questionnaire Administration" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "MyMichigan Medical Center Midland" are 16 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "MyMichigan Medical Center Midland". undefined are not yet recruiting, 4 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MyMichigan Medical Center Midland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MyMichigan Medical Center Midland, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".